Am J Physiol Endocrinol Metab (2015) 308(8):E6419
For diabetics, the glycemic benefits may factor into compound selection
Important: Researchers should consult product labeling and facility-specific protocols when establishing storage timelines and handling procedures
Science 328 , 15661569 (2010)
Williams reported that while central blockade of the GLP-1 system with ICV administration of exendin 939 blocked the actions of central but not peripheral GLP-1, peripheral (intraperitoneal) exendin 939 blocked the appetite-suppressing actions of peripheral, but not central GLP-1, indicating that the two systems do not depend on each other for activity
Drug-Drug Interactions I VIT 12 COMBINATION PACK INJECTION 2.5ML Interacts with the Following Medicines: Chemotherapy Medicines: Medications like cisplatin and doxorubicin may interact with I VIT 12 COMBINATION PACK INJECTION 2.5ML, potentially reducing the effectiveness of these cancer treatments due to the antioxidant properties of vitamin C